In this article, we are going to take a look at where Akero Therapeutics, Inc. (NASDAQ:AKRO) stands against other best booming stocks to invest in now. The U.S. stock market closed on a downbeat ...

In this article, we are going to take a look at where Akero Therapeutics, Inc. (NASDAQ:AKRO) stands against the other biotech stocks. No matter the market environment, you’ll always find ...

NEW YORK CITY, NY / ACCESS Newswire / March 20, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

In this article, we are going to take a look at where Akero Therapeutics, Inc. (NASDAQ:AKRO) stands against other best performing pharma stocks so far in 2025. On February 20, Jared Holz ...

Stay updated on market trends for AKRO. Akero Therapeutics, Brinker International And Viavi Are Among Top Mid Cap Gainers Last Week (Jan 27-Jan 31): Are The Others In Your Portfolio? Check out ...

In this article, we are going to take a look at where Akero Therapeutics Inc. (NASDAQ:AKRO) stands against other best performing mid cap stocks to buy according to analysts. On February 7 ...

Jonathan Young, the Chief Operating Officer of $AKRO, sold 607 shares of the company on 03-12-2025 for an estimated $27,242. We received data on the trade from a ...

Andrew Cheng, the President and CEO of $AKRO, sold 1,738 shares of the company on 03-12-2025 for an estimated $78,001. We received data on the trade from a recent SEC ...